Sort
4,870 grants matching “glp 1”
Safety and Efficacy of a Titratable External Shunt
$350,855Lucinda Camras · Camras Vision, Inc. · R44 · FY2017 · EY
Novel metabolic actions of GIP
$350,843Jonathan E Campbell · Duke University · R01 · FY2024 · DK
Modulation of NAc-DA Signaling by Learning Motivational State and Peptides
$350,824Mitchell F Roitman · University Of Illinois At Chicago · R01 · FY2018 · DA
Development of novel Aquilo Heat Therapy Device to treat patients with PeripheralArtery Disease
$350,681Paul Spence · Aquilo Sports, Llc · R43 · FY2022 · HL
Modulation of NAc-DA Signaling by Learning Motivational State and Peptides
$350,555Mitchell F Roitman · University Of Illinois At Chicago · R01 · FY2019 · DA
Experimental Pharmacology and Chemical Studies of Nikkomycin Z
$350,119John N Galgiani · Valley Fever Therapies Llc · R42 · FY2010 · AI
Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial
$350,000Judith A Kelleher-Andersson · Neuronascent, Inc. · U01 · FY2024 · AG
Tolerogenic Nanotherapy to Delay Type I Diabetes
$350,000Jacqueline Alexis Burke · Snc Therapeutics, Inc. · R41 · FY2025 · DK
Dissecting mechanisms by which GI surgery delays diabetes onset in UCD-T2DM rats
$349,950Peter J Havel · University Of California At Davis · R01 · FY2012 · DK
Thermostable RG1-VLPs, a candidate broadly protective HPV vaccine for the prevention of cervical cancer
$349,933Warner King Huh · Johns Hopkins University · P50 · FY2020 · CA
Aerosol Biology Small Animal Models
$349,884R Mark Buller · Washington University · U54 · FY2009 · AI
Incretin action in physiology and diabetes
$349,325David A. D'alessio · Duke University · R01 · FY2014 · DK
Noninvasive Assessment of Pancreatic Beta-Cell Mass
$348,738Orhan K Oz · Ut Southwestern Medical Center · R01 · FY2014 · DK
Neuroendocrinology of Energy Balance Control
$348,000Matthew R Hayes · University Of Pennsylvania · R01 · FY2014 · DK
Neuroendocrinology of Energy Balance Control
$348,000Matthew R Hayes · University Of Pennsylvania · R01 · FY2015 · DK
Neuroendocrinology of Energy Balance Control
$348,000Matthew R Hayes · University Of Pennsylvania · R01 · FY2012 · DK
Neuroendocrinology of Energy Balance Control
$348,000Matthew R Hayes · University Of Pennsylvania · R01 · FY2016 · DK
GLP-1 to Enhance Islet Transplantation
$347,893Vanderbilt University · R21 · FY2004 · DK
Dihydromethysticin (DHM) for Lung Cancer Chemoprevention
$347,700Chengguo Xing · University Of Minnesota · R01 · FY2015 · CA
Backbone-modified agonists of B-family GPCRs
$346,932Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2020 · GM
Backbone-modified agonists of B-family GPCRs
$346,932Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2021 · GM
Backbone-modified agonists of B-family GPCRs
$346,932Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2019 · GM
Glomerular and Tubular Function in the Diabetic Kidney
$346,833Scott C. Thomson · Veterans Medical Research Fdn/San Diego · R01 · FY2013 · DK
Targeting Estrogen Receptors to Protect Functional Beta-cell Mass in Diabetes
$346,660Franck Mauvais-Jarvis · Tulane University Of Louisiana · R01 · FY2014 · DK
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again
$346,517Bill Basinger · Countervail Corporation · R44 · FY2010 · NS